Pandemic All Hazards Preparedness Act reauthorization
CDC Funding in FY2024 and FY 2025 Labor, Health and Human Services bill, including immunization, smoking and health, social determinants of health, violence prevention, public health preparedness, epi and lab capacity, Data Modernization, Center for Forecasting Outbreak and Analytics, climate and health, overdose prevention, public health workforce, capacity and infrastructure, infectious diseases
HHS Funding for Title X and Teen Pregnancy Prevention Program
Overdose prevention, Modernizing Opioid Treatment Access Act (H.R. 1359/S. 644)
Regulation of Tobacco/Nicotine and flavors
SUPPORT for Patients and Communities Reauthorization Act (S. 3393/H.R. 4531)
Preventing Adverse Childhood Experiences Act (S. 3085)
Lead-Safe Housing for Kids Act
Vaccine Safety Systems
HRSA Public Health Loan Repayment in FY 25 LHHS bill
Oppose cuts to Prevention and Public Health Fund
Duration: January 18, 2022
to
present
General Issues: Health Issues , Tobacco , Alcohol & Drug Abuse , Budget/Appropriations
Spending: about $240,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2022: U.S. Senate, House of Representatives, Centers For Disease Control & Prevention (CDC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Venable LLP lobbied for Big Cities Health Coalition , earning $40,000. The report was filed on April 22.
Original Filing: 301574695.xml
Lobbying Issues
Pandemic All Hazards Preparedness Act reauthorization
CDC Funding in FY2024 and FY 2025 Labor, Health and Human Services bill, including immunization, smoking and health, social determinants of health, violence prevention, public health preparedness, epi and lab capacity, Data Modernization, Center for Forecasting Outbreak and Analytics, climate and health, overdose prevention, public health workforce, capacity and infrastructure, infectious diseases
HHS Funding for Title X and Teen Pregnancy Prevention Program
Overdose prevention, Modernizing Opioid Treatment Access Act (H.R. 1359/S. 644)
Regulation of Tobacco/Nicotine and flavors
SUPPORT for Patients and Communities Reauthorization Act (S. 3393/H.R. 4531)
Preventing Adverse Childhood Experiences Act (S. 3085)
Lead-Safe Housing for Kids Act
Vaccine Safety Systems
HRSA Public Health Loan Repayment in FY 25 LHHS bill
Oppose cuts to Prevention and Public Health Fund
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2023
In Q4, Venable LLP lobbied for Big Cities Health Coalition , earning $30,000. The report was filed on Jan. 20.
Original Filing: 301533823.xml
Lobbying Issues
Pandemic All Hazards Preparedness Act reauthorization
CDC Funding in FY2024 Labor, Health and Human Services bill, including immunization, smoking and health, social determinants of health, violence prevention, public health preparedness, epi and lab capacity, Data Modernization Initiative, Center for Forecasting Outbreak and Analytics, climate and health, overdose prevention, public health workforce, capacity and infrastructure, infectious diseases
HHS Funding for Title X and Teen Pregnancy Prevention Program
Overdose prevention, Modernizing Opioid Treatment Access Act (H.R. 1359/S. 644)
Regulation of Tobacco/Nicotine and flavors
Workplace Overdose Reversal Kits to Save Lives Act (H.R. 5420 / S. 2948)
SUPPORT for Patients and Communities Reauthorization Act (S. 3393)
Preventing Adverse Childhood Experiences Act (S. 3085)
Lead-Safe Housing for Kids Act
Protecting American From Seasonal and Pandemic Flu Act (H.R. 5846 / S. 3219)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2023
In Q3, Venable LLP lobbied for Big Cities Health Coalition , earning $30,000. The report was filed on Oct. 19, 2023.
Original Filing: 301507414.xml
Lobbying Issues
Pandemic All Hazards Preparedness Act reauthorization
CDC Funding in FY2024 Labor, Health and Human Services bill, including immunization, smoking and health, social determinants of health, violence prevention, public health preparedness, epi and lab capacity, Data Modernization Initiative, Center for Forecasting Outbreak and Analytics, climate and health, overdose prevention, public health workforce, capacity and infrastructure, infectious diseases
HHS Funding for Title X and Teen Pregnancy Prevention Program
Overdose prevention, Modernizing Opioid Treatment Access Act (HR 1359/S 644)
Regulation of Tobacco/Nicotine and flavors
Preventing Overdoses with Test Strips Act (S.2976)
Helping Tobacco Users Quit Act (H.R. 4775)
Safe Response Act (H.R. 4089/S.2933)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2023
In Q2, Venable LLP lobbied for Big Cities Health Coalition , earning $30,000. The report was filed on July 19, 2023.
Original Filing: 301484871.xml
Lobbying Issues
Pandemic All Hazards Preparedness Act reauthorization
CDC Funding in FY2024 Labor, Health and Human Services bill, including immunization, smoking and health, social determinants of health, violence prevention, public health preparedness, epi and lab capacity, Data Modernization Initiative, Center for Forecasting Outbreak and Analytics, climate and health, overdose prevention, public health workforce, capacity and infrastructure, infectious diseases
HHS Funding for Title X and Teen Pregnancy Prevention Program
HHS Office of National Coordinator for Health Information Technology
Overdose prevention, Modernizing Opioid Treatment Access Act (HR 1359/S 644)
Stop Fentanyl Overdoses Act (HR 3375/S 1785)
Regulation of Tobacco/Nicotine and flavors
Funding for Public Health Workforce Loan Repayment Program (HRSA)
Oppose rescinding COVID public health funding in Limit, Save, Grow Act (HR 2811)
Black Maternal Health Momnibus Act (HR 3305/ S 1606)
Improving DATA in Public Health Act (HR 3791)
Public Health Infrastructure Saves Lives Act (S 1995)
Disease X Act (HR 3832/S 2093)
Right to Contraception Act (HR 4121/ S 1999)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2023
In Q1, Venable LLP lobbied for Big Cities Health Coalition , earning $30,000. The report was filed on April 20, 2023.
Original Filing: 301463527.xml
Lobbying Issues
Pandemic All Hazards Preparedness Act reauthorization
CDC Funding in FY2024 Labor, Health and Human Services bill, including immunization, smoking and health, social determinants of health, violence prevention, public health preparedness, epi and lab capacity, Data Modernization Initiative, Center for Forecasting Outbreak and Analytics, climate and health, overdose prevention, public health workforce, capacity and infrastructure, infectious diseases
Declaring racism a public health issue Resolution
HHS Funding for Title X and Teen Pregnancy Prevention Program
Overdose prevention, Modernizing Opioid Treatment Access Act (HR 1359/S 644)
Gun Safety, Assault Weapons Ban (HR 698/S 25)
Regulation of Tobacco/Nicotine and flavors
Funding for Public Health Workforce Loan Repayment Program (HRSA)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2022
In Q4, Venable LLP lobbied for Big Cities Health Coalition , earning $20,000. The report was filed on Jan. 19, 2023.
Original Filing: 301435840.xml
Lobbying Issues
FDA regulation of tobacco, nicotine, and synthetic nicotine; Banning menthol cigarettes and flavored cigars.
Lobbying Issues
Substance use prevention, including naloxone, harm reduction, and Medication for Opioid Use Disorder; Elimination of X waiver; H.R. 1384/S. 445 - Mainstreaming Addiction Treatment Act; Delay Fentanyl scheduling as Schedule 1; S. 5167 TEST Act.
Agencies Lobbied
Centers For Disease Control & Prevention (CDC) U.S. Senate U.S. House of Representatives
Lobbying Issues
Public health data authority; H.R. 9476 Protecting America from Seasonal and Pandemic Influenza.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY 2023 Labor-HHS-Education Appropriations bill; CDC funding for Advanced Molecular Detection, immunization, smoking and health, social determinants of health, violence prevention, public health preparedness, Epi and Lab capacity, data modernization initiative, infectious disesases, opioid prevention, climate and health, public health workforce, public health capacity and infrastructure; Teen Pregnancy Prevention Program and Adolescent, School Health program and Title X; HRSA funding; FY2023 Supplemental Funding for Monkeypox and COVID.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Management & Budget (OMB)
3rd Quarter, 2022
In Q3, Venable LLP lobbied for Big Cities Health Coalition , earning $20,000. The report was filed on Oct. 17, 2022.
Original Filing: 301406432.xml
Lobbying Issues
FDA regulation of tobacco, nicotine, and synthetic nicotine; Banning menthol cigarettes and flavored cigars.
Lobbying Issues
Substance use prevention, including naloxone, harm reduction, and Medication for Opioid Use Disorder; Elimination of X waiver; H.R. 1384/S. 445 - Mainstreaming Addiction Treatment Act; Delay Fentanyl scheduling as Schedule 1.
Agencies Lobbied
Centers For Disease Control & Prevention (CDC) U.S. Senate U.S. House of Representatives
Lobbying Issues
Public health data authority; H.R. 8404/S. 4556 Respect for Marriage Act; H.R. 3467/S. 4332 Improving Data Collection for Adverse Childhood Experiences Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY 2023 Labor-HHS-Education Appropriations bill; CDC funding for Advanced Molecular Detection, immunization, smoking and health, social determinants of health, violence prevention, public health preparedness, Epi and Lab capacity, data modernization initiative, opioid prevention, climate and health, public health workforce, public health capacity and infrastructure; Teen Pregnancy Prevention Program and Adolescent, School Health program and Title X; HRSA COVID-19 uninsured program; FY2024 Funding for CDC; FY2023 Supplemental Funding for Monkeypox.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Management & Budget (OMB)
2nd Quarter, 2022
In Q2, Venable LLP lobbied for Big Cities Health Coalition , earning $20,000. The report was filed on July 19, 2022.
Original Filing: 301388330.xml
Lobbying Issues
FDA regulation of tobacco, nicotine, and synthetic nicotine; Banning menthol cigarettes and flavored cigars.
Lobbying Issues
Substance use prevention, including naloxone, harm reduction, and Medication for Opioid Use Disorder; Elimination of X waiver; H.R. 1384/S. 445 - Mainstreaming Addiction Treatment Act.
Agencies Lobbied
Centers For Disease Control & Prevention (CDC) U.S. Senate U.S. House of Representatives
Lobbying Issues
Public health data authority; S. 2938 - Bipartisan Safer Communities Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
FY 2023 Labor-HHS-Education Appropriations bill; CDC funding for Advanced Molecular Detection, immunization, smoking and health, social determinants of health, violence prevention, public health preparedness, Epi and Lab capacity, data modernization initiative, opioid prevention, climate and health, public health workforce, public health capacity and infrastructure; Teen Pregnancy Prevention Program and Adolescent, School Health program and Title X; COVID-19 uninsured program.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2022
In Q1, Venable LLP lobbied for Big Cities Health Coalition , earning $20,000. The report was filed on April 19, 2022.
Original Filing: 301364074.xml
Lobbying Issues
FDA regulation of tobacco, nicotine, and synthetic nicotine; Banning menthol cigarettes and flavored cigars.
Lobbying Issues
Substance use prevention, including naloxone, harm reduction, and Medication for Opioid Use Disorder.
Agencies Lobbied
Centers For Disease Control & Prevention (CDC) Office of Natl Drug Control Policy (NDCP)
Lobbying Issues
Strengthening public health infrastructure, workforce and data in preparation for the next pandemic; Tracking Pathogens Act (S. 3534); PREVENT Pandemics Act (S. 3799); Disease X Act (S. 2640); Newborn Screening Saves Lives Reauthorization Act (H.R. 482).
Lobbying Issues
FY 2022 and FY 2023 Labor-HHS-Education Appropriations bill; CDC funding for Advanced Molecular Detection, immunization, smoking and health, social determinants of health, violence prevention, public health preparedness, Epi and Lab capacity, data modernization initiative, climate and health, public health workforce, public health capacity and infrastructure; Teen Pregnancy Prevention Program and Adolescent and School Health program.
Agencies Lobbied
Centers For Disease Control & Prevention (CDC)
1st Quarter, 2022
Venable LLP filed a lobbying registration on March 28, 2022 to represent Big Cities Health Coalition, effective Jan. 18, 2022.
Original Filing: 301343044.xml
Issue(s) they said they’d lobby about: Public health funding at CDC, opioid prevention, violence prevention, pandemic preparedness .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate